LFWD
Lifeward Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$5.93
−1.17%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$6.09
From 52W high−34.98%
Volume6376.00
Market cap$16.79M
P/E (TTM)—
P/S (TTM)0.8x
Div yield—
Key dataOct 19, 2026
Open
$6.09
From 52W high
−34.98%
Volume
6376.00
Market cap
$16.79M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.8x
P/E (TTM)
—
RSI (14)
36.9
MomentumView details →
1D Return
−1.17%
YTD Return
−13.22%
SummaryUpdated Jun 1, 2026
ReWalk Robotics Ltd. (NASDAQ:LFWD) is an Israeli medical device company founded in 2001 that designs, develops, and commercializes robotic exoskeletons and rehabilitation devices for individuals with mobility impairments. Originally incorporated as Argo Medical Technologies Ltd., the company went public in 2014 and is headquartered in Yokneam Illit, Israel. ReWalk has evolved from a single-product exoskeleton manufacturer into a diversified mobility solutions provider through strategic acquisitions, most notably the acquisition of AlterG in 2023, which significantly expanded its product portfolio and revenue base.
Similar companies
Latest newsMore news →
Lifeward reported findings from an independent peer-reviewed study showing that ReWalk users had a median of 33 months of use, averaged more than 3,000 steps per month, and reported high satisfaction, with no falls or exoskeleton-related fractures during the observation period.6d agoLifeward Ltd. appointed Rami Aviram as Chief Financial Officer, principal financial officer and principal accounting officer, effective November 1, 2026, with Josh Hexter serving as interim principal financial officer and principal accounting officer from October 1, 2026.19d agoA peer-reviewed independent study reported that Lifeward's ReWalk exoskeleton significantly improved daily activity performance and satisfaction and reduced pain compared with wheelchair use.35d ago